We are one of the largest global pharmaceutical sourcing and distribution services companies, helping both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. We deliver innovative programs and services designed to increase the effectiveness and efficiency of the pharmaceutical supply chain in both human and animal health. Our organizational structure is aligned geographically based upon the products and services we provide to our customers, allowing for operational flexibility and adaptability in response to market demands and external pressures. The acquisition of Pharmalex is expected to enhance our global portfolio of solutions, supporting our strategic initiatives and resilience strategies by providing specialized services that improve our capacity for recovery and transformation in the life sciences industry. Our future revenue growth will continue to be affected by various factors, including industry growth trends, competition, and changes in government regulations, which require us to maintain a strong focus on resource allocation and risk assessment to navigate potential disruptions effectively. The increase in revenue and gross profit in our U.S. healthcare solutions segment was driven by overall market growth, which reflects our ability to adapt and respond to changing customer needs and market conditions. We recognize the importance of inter-organizational collaboration and knowledge absorption in enhancing our organizational capabilities and resilience. The strategic reorganization of our business and the alignment of our reporting structure are aimed at improving our operational efficiency and effectiveness, allowing us to better confront challenges and leverage opportunities in a turbulent market environment. Our operational management practices include ongoing evaluations of our performance under pressure, ensuring that we can sustain our operations and maintain organizational health even in the face of adversity. We have established mechanisms for crisis management and emergency preparedness, which are critical for maintaining continuity and resilience during unexpected situations. The financial resources generated through our operations enable us to invest in technology initiatives and other strategic tools that enhance our organizational intelligence and adaptability. Our commitment to performance maintenance and organizational evolution is evident in our approach to managing risks and uncertainties, as well as in our efforts to foster a culture of learning and innovation. We are focused on ensuring that our organizational practices support our major objectives, including the ability to foresee and respond to environmental disruptions and the complexities of the competitive landscape. The strategic planning processes we employ are designed to enhance our organizational foresight and agility, enabling us to thrive and flourish in the face of challenges and to capitalize on emerging opportunities in the healthcare sector.